Price Alert

Oramed Pharmaceuticals In... (ORMP)

NASDAQ: ORMP · Real-Time Price · USD

2.08

-0.04 (-1.89%)

At close: Aug 15, 2025, 3:59 PM

2.07

-0.48%

After-hours: Aug 15, 2025, 05:49 PM EDT

Oramed Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Nov 30, 2021	Aug 31, 2021	May 31, 2021	Feb 28, 2021
Cash & Equivalents	42.1M	84.75M	18.58M	9.05M	5.47M	6.77M	24.1M	40.46M	33.2M	29.89M	27.97M	31.88M	77.25M	57.41M	33.8M
Short-Term Investments	100.2M	67.98M	158.02M	152.99M	169.57M	143.43M	129.63M	115.26M	126.35M	104.02M	113.64M	118.66M	16.89M	12.23M	22.98M
Long-Term Investments	21.07M	29.59M	25.09M	56.37M	53.47M	3.52M	2.7M	2.7M	2.7M	684K	1.96M	4.13M	6.69M	7.29M	3.14M
Other Long-Term Assets	32K	30K	36K	34K	-55.16M	33K	31K	24K	25K	25.23M	25.18M	25.1M	25.04M	22K	22K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	533K	501K	537K	666K	769K	1.42M	1.39M	623K	958K	1.95M	1.8M	1.2M	2.59M	683K
Total Current Assets	142.77M	153.27M	177.09M	162.58M	175.71M	150.97M	155.16M	157.11M	160.17M	134.87M	143.56M	152.33M	95.34M	72.23M	57.47M
Property-Plant & Equipment	1.2M	1.33M	1.43M	1.57M	1.69M	1.79M	1.89M	1.81M	1.54M	1.5M	1.53M	889K	932K	949K	1.02M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	22.31M	30.95M	26.56M	57.97M	55.19M	5.34M	4.62M	4.53M	4.26M	27.42M	28.66M	30.12M	32.66M	8.26M	4.18M
Total Assets	165.08M	184.22M	203.65M	220.55M	230.89M	156.31M	159.78M	161.64M	164.44M	162.29M	172.22M	182.45M	128M	80.49M	61.66M
Account Payables	5M	3.48M	1.27M	551K	2.56M	828K	4.05M	2.17M	4.21M	3.48M	3.31M	4.76M	2.61M	2.86M	3M
Deferred Revenue	n/a	n/a	n/a	n/a	4M	4M	674K	1.34M	2.02M	2.7M	2.7M	2.7M	2.7M	2.7M	2.7M
Short-Term Debt	n/a	n/a	32.03M	51.01M	75.61M	236K	242K	247K	228K	233K	237K	130K	130K	129K	139K
Other Current Liabilities	35K	n/a	1K	325K	-4M	-4M	1K	1.98M	70K	1K	74K	66K	1.24M	58K	87K
Total Current Liabilities	5.27M	3.73M	33.56M	53.21M	78.17M	1.07M	4.97M	5.75M	6.53M	6.42M	6.32M	7.66M	6.68M	5.75M	5.93M
Long-Term Debt	n/a	n/a	n/a	n/a	389K	488K	564K	647K	672K	744K	871K	374K	403K	431K	469K
Other Long-Term Liabilities	4.1M	100K	103K	102K	88K	93K	85K	82K	82K	81K	121K	144K	145K	180K	197K
Total Long-Term Liabilities	4.29M	4.34M	4.38M	4.44M	4.49M	4.59M	4.66M	4.74M	4.76M	2.84M	3.68M	4.1M	4.8M	5.55M	6.28M
Total Liabilities	9.56M	8.07M	37.93M	57.66M	82.66M	5.66M	9.63M	10.49M	11.29M	9.25M	10M	11.76M	11.48M	11.3M	12.21M
Total Debt	429K	486K	32.56M	51.62M	76M	724K	806K	894K	900K	977K	1.11M	504K	533K	560K	608K
Common Stock	484K	488K	487K	485K	484K	484K	481K	476K	470K	463K	463K	458K	424K	366K	339K
Retained Earnings	-166.43M	-146.81M	-156.02M	-157.56M	-170.89M	-167.67M	-166.48M	-163.08M	-154.54M	-147.48M	-136.94M	-122.74M	-114.85M	-108M	-102.79M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	156.44M	177.06M	166.64M	163.82M	149.13M	151.55M	150.97M	151.81M	153.81M	153.7M	162.35M	170.16M	115.77M	68.12M	49.44M
Total Investments	121.27M	95.78M	181.65M	207.92M	223.04M	4.47M	4.97M	117.96M	129.05M	104.7M	115.6M	122.79M	23.59M	19.52M	26.12M